In vivo 31P magnetic resonance spectroscopy (MRS) provides direct biochemical information on hepatic metabolic processes. To assess in vivo changes in hepatic 31P MRS in liver transplant candidates, we studied 31 patients with cirrhosis of varying aetiology; 14 with compensated cirrhosis (Pugh's score <7) and 17 with decompensated cirrhosis (Pugh's score <8). Underlying cellular abnormalities were characterised using in vitro31P MRS and electron microscopy. In vitro spectra were obtained from liver extracts, freeze-clamped at recipient hepatectomy, from all subjects. Electron microscopy of liver tissue was also performed in 17 cases. Relative to nucleotide triphosphates, elevations in phosphomonoesters and reductions in phosphodiesters were...
Phosphorus (31P) metabolites are emerging liver disease biomarkers. This work aims to develop a quan...
Magnetic Resonance Spectroscopy is a powerful non-invasive tool for investigating liver metabolism i...
Purpose Phosphorus (31P) metabolites are emerging liver disease biomarkers. Of particular interest a...
Chronic liver disease is a major health problem and liver transplantation is the only form of treatm...
Hepatic phosphorus-31 magnetic resonance spectroscopy (31P MRS) was undertaken in 85 patients with h...
AbstractHuman livers with histologically proven cirrhosis were assessed using in vitro 31P NMR spect...
Human livers with histologically proven cirrhosis were assessed using in vitro 31P NMR spectroscopy....
BACKGROUND AND AIMS Alterations in gluconeogenesis in the diseased liver can be assessed non-invasiv...
Background. The purpose of this study was to investigate whether phosphorus-31 magnetic resonance sp...
Spectral changes in human hepatic tumours and possible systemic effects of tumour on host liver were...
Magnetic resonance spectroscopy (MRS) remains the technique of choice for observing tumour metabolis...
This review provides an overview of the current state of the art of magnetic resonance spectroscopy ...
1. Patients with a history of alcohol abuse were studied by 31P n.m.r. spectroscopy of the liver in ...
Hepatic infiltration by lymphoma can be difficult to detect by conventional methods. We have studied...
Phosphorus-31 magnetic resonance spectroscopy of the human liver was undertaken in 28 healthy adult ...
Phosphorus (31P) metabolites are emerging liver disease biomarkers. This work aims to develop a quan...
Magnetic Resonance Spectroscopy is a powerful non-invasive tool for investigating liver metabolism i...
Purpose Phosphorus (31P) metabolites are emerging liver disease biomarkers. Of particular interest a...
Chronic liver disease is a major health problem and liver transplantation is the only form of treatm...
Hepatic phosphorus-31 magnetic resonance spectroscopy (31P MRS) was undertaken in 85 patients with h...
AbstractHuman livers with histologically proven cirrhosis were assessed using in vitro 31P NMR spect...
Human livers with histologically proven cirrhosis were assessed using in vitro 31P NMR spectroscopy....
BACKGROUND AND AIMS Alterations in gluconeogenesis in the diseased liver can be assessed non-invasiv...
Background. The purpose of this study was to investigate whether phosphorus-31 magnetic resonance sp...
Spectral changes in human hepatic tumours and possible systemic effects of tumour on host liver were...
Magnetic resonance spectroscopy (MRS) remains the technique of choice for observing tumour metabolis...
This review provides an overview of the current state of the art of magnetic resonance spectroscopy ...
1. Patients with a history of alcohol abuse were studied by 31P n.m.r. spectroscopy of the liver in ...
Hepatic infiltration by lymphoma can be difficult to detect by conventional methods. We have studied...
Phosphorus-31 magnetic resonance spectroscopy of the human liver was undertaken in 28 healthy adult ...
Phosphorus (31P) metabolites are emerging liver disease biomarkers. This work aims to develop a quan...
Magnetic Resonance Spectroscopy is a powerful non-invasive tool for investigating liver metabolism i...
Purpose Phosphorus (31P) metabolites are emerging liver disease biomarkers. Of particular interest a...